聚合物背包装载组织透单细胞用于治疗癌症
Neha Kapate1,2,3, Michael Dunne1,2, Alexander P Gottlieb1,4
1Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.
Advanced healthcare materials
|April 6, 2024
概括
这项研究介绍了Ornate Polymer背包在组织透单细胞 (OPTIM) 上,用于重编程固体瘤中的免疫抑制性髓状细胞. 在临床前癌症模型中,OPTIMs疗法有效降低瘤负担并提高存活率.
科学领域:
- 免疫治疗是一种免疫疗法.
- 癌症生物学 癌症生物学
- 生物材料工程 生物材料工程
背景情况:
- 固体瘤对采用细胞疗法提出了挑战,原因是透率差和免疫抑制的微环境.
- 骨髓状细胞在瘤如三阴性乳腺癌中丰富,是有前途的治疗点,但表现出可塑性.
- 需要抗原独立的策略来克服瘤异质性和不响应.
研究的目的:
- 开发一种新的治疗策略,利用单细胞贩运来治疗固体瘤.
- 用工程生物材料控制瘤微环境中的单细胞分化.
- 调查OPTIMs在减少瘤负担和改善生存率方面的潜力.
主要方法:
- 用含有干扰素玛 (IFNγ) 的表面粘附"背包"进行工程设计的单细胞的采用转移.
- 在组织透单细胞 (OPTIM) 上开发装饰性聚合物背包,以诱导促炎性巨细胞表型.
- 用OPTIM治疗4T1瘤携带的小鼠,随后分析瘤负担,存活率和瘤微环境.
主要成果:
- 在4T1小鼠模型中,OPTIMs治疗显著降低了瘤负担.
- 使用OPTIM治疗导致动物生存率显著增加.
- 免疫和细胞因子分析表明,OPTIMs重塑了瘤微环境,使其处于一种促炎状态.
结论:
- OPTIMs代表了一种有前途的抗原独立治疗固体瘤的方法.
- 通过生物材料结合工程髓质细胞可塑性可以克服免疫抑制瘤微环境.
- 这一策略有可能提高采用细胞治疗在挑战性癌症类型中的疗效.
更多相关视频
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
12.3K
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
14.4K
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.